Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer episode artwork

EPISODE · Dec 26, 2023 · 1H 3M

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.

Episode metadata supplied by the publisher feed · Published Dec 26, 2023

Embed this episode

NOW PLAYING

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

0:00 1:03:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 3 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on December 26, 2023.

Can I download this The Long Run with Luke Timmerman episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!